Orlando, FL – April 15, 2009 -  FormularyDecisions.com, an online platform for healthcare decision makers, is being officially introduced at AMCP’s 21st Annual Meeting and Showcase by Dymaxium, Inc. and a Steering Committee of prominent healthcare decision makers (HCDMs).

Today, HCDMs can be overwhelmed with an overload of information, including binders upon binders of paper-based dossiers, an abundance of economic models, and other content that may be used in formulary reviews and decision making.  Independent focus groups and partnership with leading HCDMs have identified a tremendous need for decision makers to more easily connect and collaborate with one another and with product manufacturers in order to make informed decisions.

FormularyDecisions.com is the solution to these challenges.  This online platform for a community of HCDMs allows 24/7, interactive, searchable access to key information and shared best practices, provides innovative decision support tools, and fosters communication and collaboration between HCDMs and manufacturers.

FormularyDecisions.com will involve product manufacturers who have a common goal with HCDMs to improve evidence-based decisions through increased use of clinical and economic information, streamline the review process using leading edge decision support tools, and foster communication and collaboration with the HCDM community.  Charter supporters from the pharmaceutical industry have already embraced platforms - like eDossiers, online models, and data analysis tools - in an effort to better meet the needs of HCDMs. 

FormularyDecisions.com will be officially launched in late Spring 2009, with a full global release to follow.  HCDMs can REGISTER NOW to receive a complimentary consultation about www.FormularyDecisions.com, gain insights into what opportunities this platform will offer, and be provided immediate access at launch.  There is no cost to HCDMs who wish to access this secure platform, however, registration is exclusively for those who are directly involved in formulary and/or benefit design decisions. 

FormularyDecisions.com Steering Committee Members

Steven Avey, MS, RPh, Douglas S. Burgoyne, PharmD, David C. Calabrese, RPh, MHP, Jeffrey D. Dunn, PharmD, MBA, and Celynda G. Tadlock, PharmD, MBA.

About Dymaxium, Inc.

Dymaxium is a global provider of consulting services focused on maximizing the communication and application of clinical, economic, and humanistic outcomes research.

To learn more, please contact:press@FormularyDecisions.com or 1-888-876-7050 ext 505

Allen Lising, Managing Director or Bridget Olson, VP Decision Maker Partnerships